跳至主要内容
临床试验/CTRI/2024/03/064721
CTRI/2024/03/064721尚未招募3 期

Randomized controlled clinical trial to evaluate an add on effect of Tagar Vati in the management of Essential Hypertension. - NI

Dr Vidya Rajendra Jatti0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having Stage I hypertension, isolated systolic and isolated diastolic hypertension.
  • 2. Patients who is known case of Hypertension but not suffering from more than 10 years. Also known case of hypertension with or without antihypertensive.
  • 3. Shirashool, Bhrama, Klama, Hridspandana, Anidra, Swedadhikya ,Shwaskashtata patient having these symptoms of Hypertension will be included in the clinical study .
  • 4. Patients in between 20 to 60 years of age.
  • 5. Patients having serum creatinine level less than 1.5 mg/dl.
  • 6. Patients with raised blood pressure with Beta blocker.

排除标准

  • 1. Patients having Stage II, stage III and above known case of hypertension will be excluded.
  • 2. Pregnant women and lactating mothers.
  • 3. Patient suffering from any other serious systemic illness like cerebrovascular diseases, Acute Haemorrhagic conditions, Acute septic shock etc.

研究者

发起方
Dr Vidya Rajendra Jatti

相似试验